| Title | Date | PubMed ID |
|---|
| N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy. | 2015 Feb | 25281698 |
| Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. | 2014 | 24918438 |
| Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli. | 2009 Sep 30 | 19788761 |
| Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells. | 2008 Jul 1 | 18398838 |
| IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. | 2008 Feb | 18172551 |
| Glycan microarrays for screening sialyltransferase specificities. | 2008 Jan | 17914671 |
| ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. | 2006 Jan | 16135558 |
| Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. | 2004 Oct 1 | 15466199 |
| Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. | 2003 Jun | 12754287 |
| Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer. | 2002 Jan | 11984005 |